Why are drug prices so high? Investigating th...

Have you ever recalled a story only to have someone point out "that's not how it went"? Well, what happens when what we misrepresent are our historical narratives? David Ikard is a Professor of African American and Diaspora Studies at Vanderbilt University. In this episode, he ta ...  Show more

What if the calm you feel when you hear birdsong isn't a coincidence, but ancient evolutionary wiring ... a signal that once meant safety? Musical ecologist and rapper Louis VI says humans are hardwired to nature's sonic language, but modern life has drowned it out. He explores h ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...